Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia

This publication has 141 references indexed in Scilit:

• The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of function
  Leukemia, 2010
• Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
  Nature Genetics, 2010
• A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
  Cancer Cell, 2010
• PHF6 mutations in T-cell acute lymphoblastic leukemia
  Nature Genetics, 2010
• Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia
  Leukemia, 2009
• Direct inhibition of the NOTCH transcription factor complex
  Nature, 2009
• NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia
  Leukemia, 2009
• γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
  Nature Medicine, 2008
• Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27^Kip1 and p57^Kip2
  EMBO Reports, 2008
• Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia
  Nature Genetics, 2007